Nitrites and Nitrosamines in Pharmaceuticals
Understanding their impact and ensuring compliance Nitrosamines, especially those formed through nitrites, remain a significant concern in pharmaceutical safety. Staying compliant with evolving regulations is crucial. This session will provide insights on:
Proactive Compliance:
Building Adaptive Quality Systems to Navigate Future Regulatory Landscapes This session covers:
Next-Gen Biologics Characterisation:
Pushing Boundaries
Continuous Manufacturing:
Transforming Pharmaceutical Production for Efficiency and Agility
The Smart Lab Revolution:
Digitalisation and Automation for Enhanced QA/QC Efficiency and Reliability
Innovation vs. Regulation:
Balancing the Pace of Analytical Technological Advancement with Evolving Regulatory Frameworks The pharmaceutical industry has experienced considerable transformation over the past decade, characterized by a notable shift towards biologics and a revived focus on peptide and oligonucleotide drug modalities. It has also witnessed significant changes in the regulatory landscape, particularly with the recent implementation of […]
Empowering 5.0 Biosolutions through Realtime PAT and Computational Controls
Innovative Technologies for Rapid and Sensitive Endotoxin Detection
